Breaking News Instant updates and real-time market news.

DGLY

Digital Ally

$2.96

0.16 (5.71%)

, AAXN

Axon

$66.77

-1.58 (-2.31%)

08:45
10/02/18
10/02
08:45
10/02/18
08:45

The Patent and Trademark office sides with Digital Ally in Axon dispute

Digital Ally (DGLY) announced a new development in its ongoing legal battles against Axon (AAXN). The Patent and Trademark Office rejected Axon's most recent challenge to Digital's law enforcement patent portfolio. Axon has now filed six unsuccessful validity challenges with the Patent Office. In this latest instance, Axon asked the Patent Office to invalidate Digital's U.S. Patent No. 9,712,730, which is not currently involved in any active litigation. The Patent Office rejected Axon's latest challenge finding that "[u]pon consideration of [Axon's] Petition and [Digital's] Preliminary Response, we conclude that the information presented in the Petition does not demonstrate that it is more likely than not at least one of the challenged claims is unpatentable. Accordingly, we do not institute a post-grant review." To date, Axon has filed an ex parte reexamination challenge, four different inter partes review challenges, and one post-grant review challenge against various Digital Ally law enforcement patents. None were successful.

DGLY

Digital Ally

$2.96

0.16 (5.71%)

AAXN

Axon

$66.77

-1.58 (-2.31%)

DGLY Digital Ally
$2.96

0.16 (5.71%)

11/16/17
MAXM
11/16/17
NO CHANGE
Target $4
MAXM
Buy
Digital Ally price target lowered to $4 from $9 at Maxim
Maxim analyst Brian Kinstlinger lowered his price target on Digital Ally (DGLY) to $4, saying Q3 results showed revenue remains depressed while the low $316k cash balance means the company will have to raise cash before year-end. Kinstlinger keeps his Buy rating, noting the company's strategic alternatives review as well as its patent infringement suit against Axon (AAXN) that could produce shareholder value, but says it is difficult to predict the outcome of litigation.
04/13/18
MAXM
04/13/18
DOWNGRADE
MAXM
Hold
Digital Ally downgraded to Hold from Buy at Maxim
04/13/18
04/13/18
DOWNGRADE

Hold
Digital Ally downgraded to Hold on expectations for more share losses at Maxim
As previously reported, Maxim analyst Brian Kinstlinger downgraded Digital Ally (DGLY) to Hold from Buy after the company reported revenue that missed his estimates, which the company blamed on competitor Axon (AAXN) giving away free product and cloud storage for one year. Kinstlinger sees Digital Ally's core business losing additional market share and believes additional dilution of shareholders capital raising is likely in the next six months.
AAXN Axon
$66.77

-1.58 (-2.31%)

08/08/18
08/08/18
DOWNGRADE
Target $62

Hold
Axon downgraded to Hold on valuation at Craig-Hallum
As previously reported, Craig-Hallum analyst Steve Dyer downgraded Axon to Hold from Buy and raised his price target on the shares to $62 from $55. The analyst acknowledges that the company continues to do a "solid job" executing against several goals laid out at last November's Analyst Day and continues to impressively expand a TAM that was once considered a niche, but revenue growth is slowing and 2H18 will potentially mark the slowest rate since 2011. Further, he believes the 155% year to date move in the stock likely captures near-term momentum and puts the stock at a level where risk/reward is more appropriately balanced.
08/08/18
IMPC
08/08/18
UPGRADE
IMPC
Outperform
Axon upgraded to Outperform from In-Line at Imperial Capital
08/08/18
IMPC
08/08/18
UPGRADE
Target $62
IMPC
Outperform
Imperial upgrades Axon to Outperform amid post-earnings selloff
Imperial Capital analyst Saliq Khan upgraded Axon Enterprise to Outperform from In-Line and raised his price target for the shares to $62 from $50. The stock in intraday trading is down 11.5%, or $7.77, to $59.85 following the company's Q2 results. Axon's efforts to create an end-to-end public safety platform, from weapons to data and records management, is likely to see continued growth for the next several years, Khan tells investors in a post-earnings research note. He attributes today's selloff to the 100 basis point hit to fiscal 2018 adjusted EBITDA margin as a result of the Vievu acquisition integration, reselling DJI drones at a lower margin, and the increase in operating expenses and investments in the Weapons segment. The analyst the building of a recurring revenue model is key to his long-term optimism on Axon.
09/14/18
RAJA
09/14/18
INITIATION
Target $79
RAJA
Outperform
Axon initiated with an Outperform at Raymond James
Raymond James initiated Axon with an Outperform and $79 price target.

TODAY'S FREE FLY STORIES

CTL

CenturyLink

$15.22

-0.18 (-1.17%)

06:08
01/24/19
01/24
06:08
01/24/19
06:08
Downgrade
CenturyLink rating change  »

CenturyLink downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 25

    Feb

ASND

Ascendis Pharma

$73.16

-0.47 (-0.64%)

06:07
01/24/19
01/24
06:07
01/24/19
06:07
Upgrade
Ascendis Pharma rating change  »

Ascendis Pharma upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FFIV

F5 Networks

06:07
01/24/19
01/24
06:07
01/24/19
06:07
Recommendations
F5 Networks analyst commentary  »

F5 Networks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLTH

Duluth Holdings

$20.41

0.425 (2.13%)

06:07
01/24/19
01/24
06:07
01/24/19
06:07
Upgrade
Duluth Holdings rating change  »

Duluth Holdings upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSANY

Nissan

$0.00

(0.00%)

, RNSDF

Renault

$0.00

(0.00%)

06:06
01/24/19
01/24
06:06
01/24/19
06:06
Hot Stocks
Nissan plans April investor meeting to oust Ghosn from board »

Nissan (NSANY) announced…

NSANY

Nissan

$0.00

(0.00%)

RNSDF

Renault

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGI

Triumph Group

$13.27

-0.07 (-0.52%)

, BDRBF

Bombardier

$0.00

(0.00%)

06:05
01/24/19
01/24
06:05
01/24/19
06:05
Hot Stocks
Bombardier to acquire Global 7500 aircraft wing program from Triumph Group »

Bombardier (BDRBF)…

TGI

Triumph Group

$13.27

-0.07 (-0.52%)

BDRBF

Bombardier

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

RNSDF

Renault

$0.00

(0.00%)

06:05
01/24/19
01/24
06:05
01/24/19
06:05
Periodicals
Renault's board asked to name Senard, Bollare to replace Ghosn, Reuters says »

Renault's board will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$9.04

0.195 (2.20%)

06:03
01/24/19
01/24
06:03
01/24/19
06:03
Periodicals
Deutsche Bank gets inquiry from House panels on Trump ties, Reuters reports »

Deutsche Bank has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$99.46

-1.16 (-1.15%)

06:03
01/24/19
01/24
06:03
01/24/19
06:03
Downgrade
Post Holdings rating change  »

Post Holdings downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 01

    Feb

MTL

Mechel

$2.50

0.075 (3.10%)

06:01
01/24/19
01/24
06:01
01/24/19
06:01
Hot Stocks
Mechel launches steel trade online store »

Mechel reports launching…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RNSDF

Renault

$0.00

(0.00%)

, NSANY

Nissan

$0.00

(0.00%)

06:01
01/24/19
01/24
06:01
01/24/19
06:01
Periodicals
Carlos Ghosn resigns as head of Renault, Bloomberg reports »

Carlos Ghosn has resigned…

RNSDF

Renault

$0.00

(0.00%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URGN

UroGen Pharma

$45.90

-7.6 (-14.21%)

06:00
01/24/19
01/24
06:00
01/24/19
06:00
Syndicate
UroGen Pharma 3.66M share Secondary priced at $41.00 »

Goldman Sachs, JPMorgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

GRBK

Green Brick

$8.13

0.13 (1.63%)

06:00
01/24/19
01/24
06:00
01/24/19
06:00
Initiation
Green Brick initiated  »

Green Brick initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EHTH

eHealth

$51.39

6.01 (13.24%)

05:59
01/24/19
01/24
05:59
01/24/19
05:59
Syndicate
eHealth 2.4M share Secondary priced at $48.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

INCY

Incyte

$75.20

-2.11 (-2.73%)

05:59
01/24/19
01/24
05:59
01/24/19
05:59
Upgrade
Incyte rating change  »

Incyte upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

BID

Sotheby's

$41.07

-0.27 (-0.65%)

05:57
01/24/19
01/24
05:57
01/24/19
05:57
Downgrade
Sotheby's rating change  »

Sotheby's downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

05:57
01/24/19
01/24
05:57
01/24/19
05:57
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

FISV

Fiserv

$80.62

2.32 (2.96%)

05:57
01/24/19
01/24
05:57
01/24/19
05:57
Upgrade
Fiserv rating change  »

Fiserv upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$49.59

-0.4 (-0.80%)

05:57
01/24/19
01/24
05:57
01/24/19
05:57
Downgrade
Canada Goose rating change  »

Canada Goose downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRS

Northern Trust

$89.93

-0.67 (-0.74%)

05:56
01/24/19
01/24
05:56
01/24/19
05:56
Downgrade
Northern Trust rating change  »

Northern Trust downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Feb

  • 28

    Feb

UMC

UMC

$1.84

-0.01 (-0.54%)

05:55
01/24/19
01/24
05:55
01/24/19
05:55
Downgrade
UMC rating change  »

UMC downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBF

SoftBank

$0.00

(0.00%)

05:55
01/24/19
01/24
05:55
01/24/19
05:55
Periodicals
SoftBank's Vision Fund to make $100M investment in Globality, WSJ reports »

SoftBank is investing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPSN

LivePerson

$21.38

0.7 (3.38%)

05:55
01/24/19
01/24
05:55
01/24/19
05:55
Upgrade
LivePerson rating change  »

LivePerson upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MB

Mindbody

$36.41

-0.19 (-0.52%)

05:54
01/24/19
01/24
05:54
01/24/19
05:54
Downgrade
Mindbody rating change  »

Mindbody downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYMTF

Hyundai Motor

$0.00

(0.00%)

05:54
01/24/19
01/24
05:54
01/24/19
05:54
Downgrade
Hyundai Motor rating change  »

Hyundai Motor downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.